Nanosized bioceramic particles could function as efficient gene delivery vehicles with target specificity for the spleen
We have compared the ability of several nanosized bioceramic particles including negatively charged silica (SiO 2 ), neutrally charged hydroxyapatite (HA) and positively charged zirconia (ZrO 2 ) nanoparticles as non-viral vectors for efficient in vivo gene delivery. A mixture of highly monodisperse...
Gespeichert in:
| Veröffentlicht in: | Gene therapy Jg. 14; H. 10; S. 828 - 835 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
London
Nature Publishing Group UK
01.05.2007
Nature Publishing Group |
| Schlagworte: | |
| ISSN: | 0969-7128, 1476-5462 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | We have compared the ability of several nanosized bioceramic particles including negatively charged silica (SiO
2
), neutrally charged hydroxyapatite (HA) and positively charged zirconia (ZrO
2
) nanoparticles as non-viral vectors for efficient
in vivo
gene delivery. A mixture of highly monodispersed aqueous suspension of HA or SiO
2
nanoparticles, coated with protamine sulfate (PS), complexed efficiently with plasmid DNA and significantly enhanced transgene expression
in vitro
. In comparison, ZrO
2
nanoparticles gave poor transfection efficiency under similar conditions tested. It was also determined that, under the same conditions, PS-SiO
2
-DNA, but not PS-HA-DNA-nanoplexes, were able to mediate efficient transgene expression
in vitro
in the presence of 50% serum. Intraperitoneal injections of PS-SiO
2
-luciferase DNA nanoplexes targeted the highest level of transgene expression in the spleen of recipient mice that lasted for more than 48 h. Injection of PS-SiO
2
-pNGVL-hFLex-MUC-1 nanoplexes was able to mediate the production of Flt-3L in the sera of recipient mice. Simultaneously, the production of Flt-3L was accompanied by the stimulation of IL-2 and interferon-
γ
(IFN-
γ
). Most importantly, the injection of PS-SiO
2
-pNGVL-hFLex-MUC-1 nanoplexes could mount potent anti-tumour specific immune responses that led to the subsequent regression of parental tumor cells containing the muc-1 determinant. |
|---|---|
| AbstractList | We have compared the ability of several nanosized bioceramic particles including negatively charged silica (SiO sub(2)), neutrally charged hydroxyapatite (HA) and positively charged zirconia (ZrO sub(2)) nanoparticles as non-viral vectors for efficient in vivo gene delivery. A mixture of highly monodispersed aqueous suspension of HA or SiO sub(2) nanoparticles, coated with protamine sulfate (PS), complexed efficiently with plasmid DNA and significantly enhanced transgene expression in vitro. In comparison, ZrO sub(2) nanoparticles gave poor transfection efficiency under similar conditions tested. It was also determined that, under the same conditions, PS-SiO sub(2)-DNA, but not PS-HA-DNA-nanoplexes, were able to mediate efficient transgene expression in vitro in the presence of 50% serum. Intraperitoneal injections of PS-SiO sub(2)- luciferase DNA nanoplexes targeted the highest level of transgene expression in the spleen of recipient mice that lasted for more than 48 h. Injection of PS- SiO sub(2)-pNGVL-hFLex-MUC-1 nanoplexes was able to mediate the production of Flt- 3L in the sera of recipient mice. Simultaneously, the production of Flt-3L was accompanied by the stimulation of IL-2 and interferon-[gamma] (IFN- [gamma]). Most importantly, the injection of PS-SiO sub(2)-pNGVL-hFLex-MUC-1 nanoplexes could mount potent anti-tumour specific immune responses that led to the subsequent regression of parental tumor cells containing the muc-1 determinant. We have compared the ability of several nanosized bioceramic particles including negatively charged silica (SiO(2)), neutrally charged hydroxyapatite (HA) and positively charged zirconia (ZrO(2)) nanoparticles as non-viral vectors for efficient in vivo gene delivery. A mixture of highly monodispersed aqueous suspension of HA or SiO(2) nanoparticles, coated with protamine sulfate (PS), complexed efficiently with plasmid DNA and significantly enhanced transgene expression in vitro. In comparison, ZrO(2) nanoparticles gave poor transfection efficiency under similar conditions tested. It was also determined that, under the same conditions, PS-SiO(2)-DNA, but not PS-HA-DNA-nanoplexes, were able to mediate efficient transgene expression in vitro in the presence of 50% serum. Intraperitoneal injections of PS-SiO(2)-luciferase DNA nanoplexes targeted the highest level of transgene expression in the spleen of recipient mice that lasted for more than 48 h. Injection of PS-SiO(2)-pNGVL-hFLex-MUC-1 nanoplexes was able to mediate the production of Flt-3L in the sera of recipient mice. Simultaneously, the production of Flt-3L was accompanied by the stimulation of IL-2 and interferon-gamma (IFN-gamma). Most importantly, the injection of PS-SiO(2)-pNGVL-hFLex-MUC-1 nanoplexes could mount potent anti-tumour specific immune responses that led to the subsequent regression of parental tumor cells containing the muc-1 determinant. We have compared the ability of several nanosized bioceramic particles including negatively charged silica (SiO(2)), neutrally charged hydroxyapatite (HA) and positively charged zirconia (ZrO(2)) nanoparticles as non-viral vectors for efficient in vivo gene delivery. A mixture of highly monodispersed aqueous suspension of HA or SiO(2) nanoparticles, coated with protamine sulfate (PS), complexed efficiently with plasmid DNA and significantly enhanced transgene expression in vitro. In comparison, ZrO(2) nanoparticles gave poor transfection efficiency under similar conditions tested. It was also determined that, under the same conditions, PS-SiO(2)-DNA, but not PS-HA-DNA-nanoplexes, were able to mediate efficient transgene expression in vitro in the presence of 50% serum. Intraperitoneal injections of PS-SiO(2)-luciferase DNA nanoplexes targeted the highest level of transgene expression in the spleen of recipient mice that lasted for more than 48 h. Injection of PS-SiO(2)-pNGVL-hFLex-MUC-1 nanoplexes was able to mediate the production of Flt-3L in the sera of recipient mice. Simultaneously, the production of Flt-3L was accompanied by the stimulation of IL-2 and interferon-gamma (IFN-gamma). Most importantly, the injection of PS-SiO(2)-pNGVL-hFLex-MUC-1 nanoplexes could mount potent anti-tumour specific immune responses that led to the subsequent regression of parental tumor cells containing the muc-1 determinant.We have compared the ability of several nanosized bioceramic particles including negatively charged silica (SiO(2)), neutrally charged hydroxyapatite (HA) and positively charged zirconia (ZrO(2)) nanoparticles as non-viral vectors for efficient in vivo gene delivery. A mixture of highly monodispersed aqueous suspension of HA or SiO(2) nanoparticles, coated with protamine sulfate (PS), complexed efficiently with plasmid DNA and significantly enhanced transgene expression in vitro. In comparison, ZrO(2) nanoparticles gave poor transfection efficiency under similar conditions tested. It was also determined that, under the same conditions, PS-SiO(2)-DNA, but not PS-HA-DNA-nanoplexes, were able to mediate efficient transgene expression in vitro in the presence of 50% serum. Intraperitoneal injections of PS-SiO(2)-luciferase DNA nanoplexes targeted the highest level of transgene expression in the spleen of recipient mice that lasted for more than 48 h. Injection of PS-SiO(2)-pNGVL-hFLex-MUC-1 nanoplexes was able to mediate the production of Flt-3L in the sera of recipient mice. Simultaneously, the production of Flt-3L was accompanied by the stimulation of IL-2 and interferon-gamma (IFN-gamma). Most importantly, the injection of PS-SiO(2)-pNGVL-hFLex-MUC-1 nanoplexes could mount potent anti-tumour specific immune responses that led to the subsequent regression of parental tumor cells containing the muc-1 determinant. We have compared the ability of several nanosized bioceramic particles including negatively charged silica (SiO 2 ), neutrally charged hydroxyapatite (HA) and positively charged zirconia (ZrO 2 ) nanoparticles as non-viral vectors for efficient in vivo gene delivery. A mixture of highly monodispersed aqueous suspension of HA or SiO 2 nanoparticles, coated with protamine sulfate (PS), complexed efficiently with plasmid DNA and significantly enhanced transgene expression in vitro . In comparison, ZrO 2 nanoparticles gave poor transfection efficiency under similar conditions tested. It was also determined that, under the same conditions, PS-SiO 2 -DNA, but not PS-HA-DNA-nanoplexes, were able to mediate efficient transgene expression in vitro in the presence of 50% serum. Intraperitoneal injections of PS-SiO 2 -luciferase DNA nanoplexes targeted the highest level of transgene expression in the spleen of recipient mice that lasted for more than 48 h. Injection of PS-SiO 2 -pNGVL-hFLex-MUC-1 nanoplexes was able to mediate the production of Flt-3L in the sera of recipient mice. Simultaneously, the production of Flt-3L was accompanied by the stimulation of IL-2 and interferon- γ (IFN- γ ). Most importantly, the injection of PS-SiO 2 -pNGVL-hFLex-MUC-1 nanoplexes could mount potent anti-tumour specific immune responses that led to the subsequent regression of parental tumor cells containing the muc-1 determinant. We have compared the ability of several nanosized bioceramic particles including negatively charged silica (SiO2), neutrally charged hydroxyapatite (HA) and positively charged zirconia (ZrO2) nanoparticles as non-viral vectors for efficient in vivo gene delivery. A mixture of highly monodispersed aqueous suspension of HA or SiO2 nanoparticles, coated with protamine sulfate (PS), complexed efficiently with plasmid DNA and significantly enhanced transgene expression in vitro. In comparison, ZrO2 nanoparticles gave poor transfection efficiency under similar conditions tested. It was also determined that, under the same conditions, PS-SiO2-DNA, but not PS-HA-DNA-nanoplexes, were able to mediate efficient transgene expression in vitro in the presence of 50% serum. Intraperitoneal injections of PS-SiO2-luciferase DNA nanoplexes targeted the highest level of transgene expression in the spleen of recipient mice that lasted for more than 48 h. Injection of PS-SiO2-pNGVL-hFLex-MUC-1 nanoplexes was able to mediate the production of Flt-3L in the sera of recipient mice. Simultaneously, the production of Flt-3L was accompanied by the stimulation of IL-2 and interferon-γ (IFN-γ). Most importantly, the injection of PS-SiO2-pNGVL-hFLex-MUC-1 nanoplexes could mount potent anti-tumour specific immune responses that led to the subsequent regression of parental tumor cells containing the muc-1 determinant. |
| Audience | Academic |
| Author | Ho, I A W Lam, P Y P Tan, K Cheang, P Hui, K M |
| Author_xml | – sequence: 1 givenname: K surname: Tan fullname: Tan, K organization: School of Chemical and Biomedical Engineering, Nanyang Technological University – sequence: 2 givenname: P surname: Cheang fullname: Cheang, P organization: School of Chemical and Biomedical Engineering, Nanyang Technological University – sequence: 3 givenname: I A W surname: Ho fullname: Ho, I A W organization: Division of Cellular & Molecular Research, National Cancer Centre – sequence: 4 givenname: P Y P surname: Lam fullname: Lam, P Y P organization: Division of Cellular & Molecular Research, National Cancer Centre – sequence: 5 givenname: K M surname: Hui fullname: Hui, K M email: cmrhkm@nccs.com.sg organization: School of Chemical and Biomedical Engineering, Nanyang Technological University, Division of Cellular & Molecular Research, National Cancer Centre |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18725022$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17344903$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkstrGzEQxkVJaRy3x16LaGigh3UlrbSPYwh9BEILfZyFVju7lllLrqRN4_711WIX1yGhSCA0_L6Z0eg7QyfWWUDoJSULSvLqXVgt-rjIc8LqvHyCZpSXRSZ4wU7QjNRFnZWUVafoLIQVIYSXFXuGTmmZc16TfIbuPivrgvkNLW6M0-DV2mi8UT4aPUDA2o1Di7vR6micxSpg6DqjDdiIe7CAWxjMLfgtvoXlTvLLxCWOyvcQcdiANhMft7hzHsclpNgAYJ-jp50aArzYn3P048P771efspsvH6-vLm8yLcoqZqJljaBQp96LXJR5WqLOheJNJxpF66pNIaqZFkQxpViuaSugpR1wTZp0n6OLXd6Ndz9HCFGuTdAwDMqCG4MsCS9qVov_gqmW4KSYMp7fA1du9DY9QrKC8yI1lPYcvX6UolVJOSfikKpXA0hjOxe90lNdeUkrxipS1VWiFg9QabWQPivZoTMpfiR4eyRITIS72KsxBHn97esxe_EPuwQ1xGVwwzh9dzgGX-0fNDZraOXGm7XyW_nXSwl4swdU0GrovLLahANXlUwQNs0v23HauxA8dAeEyMnTMqxkH-Xe04nP7_HJTmrqL43BDI-q9kMLKbvtwR_m_7DgDxs1Bqg |
| CitedBy_id | crossref_primary_10_1002_app_34140 crossref_primary_10_1088_0957_4484_22_10_105708 crossref_primary_10_1016_j_ceramint_2021_07_100 crossref_primary_10_1002_adhm_201901695 crossref_primary_10_18502_ijrm_v13i9_7671 crossref_primary_10_1007_s11051_011_0708_1 crossref_primary_10_3892_etm_2019_7158 crossref_primary_10_1016_j_bioactmat_2021_01_020 crossref_primary_10_1016_j_jconrel_2019_09_009 crossref_primary_10_1039_c2jm31109g crossref_primary_10_1515_ejnm_2015_0015 crossref_primary_10_1002_jssc_201700028 crossref_primary_10_1002_bit_23041 crossref_primary_10_1021_acs_chemrev_7b00258 crossref_primary_10_1159_000453446 crossref_primary_10_3390_biophysica4010006 crossref_primary_10_3892_mmr_2017_6583 crossref_primary_10_1016_j_biomaterials_2012_10_001 crossref_primary_10_4028_www_scientific_net_KEM_441_307 crossref_primary_10_1016_j_actbio_2011_06_018 crossref_primary_10_1186_1556_276X_6_600 crossref_primary_10_1002_cbic_200900341 crossref_primary_10_1002_chem_201705723 crossref_primary_10_2217_fon_12_171 crossref_primary_10_1016_j_aca_2009_05_037 crossref_primary_10_1016_j_nano_2009_05_003 crossref_primary_10_1007_s11051_011_0353_8 crossref_primary_10_1007_s11051_015_3316_7 crossref_primary_10_1016_S1003_6326_11_60929_1 crossref_primary_10_2147_IJN_S360670 |
| Cites_doi | 10.1002/jcb.20796 10.1016/j.jconrel.2003.11.019 10.1038/nri1669 10.1038/sj.gt.3302365 10.1016/S0065-2660(05)53003-7 10.1016/S0142-9612(03)00066-8 10.1211/002235703765951311 10.1038/sj.gt.3302639 10.1038/sj.gt.3301923 10.1038/nbt843 10.1038/nrg1577 10.1038/sj.gt.3301783 10.1016/S0049-3848(98)00201-1 10.1016/S0065-2660(05)53002-5 10.1016/j.biopha.2004.01.003 10.4049/jimmunol.174.5.2612 10.1038/nrd1960 10.1021/la049304f 10.1038/nrg1829 10.1038/sj.gt.3301759 10.1038/sj.gt.3301914 10.1016/j.ymthe.2006.03.026 10.1124/pr.58.1.8 10.1096/fj.05-5411fje |
| ContentType | Journal Article |
| Copyright | Springer Nature Limited 2007 2007 INIST-CNRS COPYRIGHT 2007 Nature Publishing Group Copyright Nature Publishing Group May 2007 Nature Publishing Group 2007. |
| Copyright_xml | – notice: Springer Nature Limited 2007 – notice: 2007 INIST-CNRS – notice: COPYRIGHT 2007 Nature Publishing Group – notice: Copyright Nature Publishing Group May 2007 – notice: Nature Publishing Group 2007. |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM ISR 3V. 7QP 7TK 7TM 7U9 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U RC3 7QO 7X8 |
| DOI | 10.1038/sj.gt.3302937 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Local Electronic Collection Information Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection PML(ProQuest Medical Library) Research Library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts Biotechnology Research Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest SciTech Collection ProQuest Medical Library ProQuest Central (Alumni) Biotechnology Research Abstracts MEDLINE - Academic |
| DatabaseTitleList | Genetics Abstracts MEDLINE MEDLINE - Academic Research Library Prep Research Library Prep |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1476-5462 |
| EndPage | 835 |
| ExternalDocumentID | 1267758271 A182280898 17344903 18725022 10_1038_sj_gt_3302937 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Singapore |
| GeographicLocations_xml | – name: Singapore |
| GroupedDBID | --- -Q- .55 .GJ 0R~ 29H 2WC 36B 39C 3V. 4.4 406 53G 5GY 70F 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AACDK AANZL AASML AATNV AAYZH AAZLF ABAKF ABAWZ ABDBF ABJNI ABLJU ABUWG ABZZP ACAOD ACGFS ACKTT ACMJI ACPRK ACRQY ACUHS ACZOJ ADBBV ADFRT ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ASPBG AVWKF AXYYD AZFZN AZQEC B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DU5 DWQXO E3Z EAD EAP EBC EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL ESX F5P FDQFY FEDTE FERAY FIGPU FIZPM FSGXE FYUFA GNUQQ GUQSH HCIFZ HMCUK HVGLF HZ~ IAO IEA IGG IHR IHW INH INR ISR ITC IWAJR JSO JZLTJ KQ8 LK8 M1P M2O M7P N9A NAO NQJWS O9- OK1 OVD PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UDS UKHRP W2D X7M Y6R ~8M AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFFHD AFHIU AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PQGLB IQODW NXXTH CGR CUY CVF ECM EIF NPM ACMFV 7QP 7TK 7TM 7U9 7XB 8FD 8FK FR3 H94 K9. MBDVC P64 PKEHL PQEST PQUKI PRINS Q9U RC3 7QO 7X8 PUEGO |
| ID | FETCH-LOGICAL-c578t-5d2b51e9000635737375935a4bf5ba198d3731c2c50a2aa23c1d5ed1fe4c0ba23 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 51 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000246210900005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0969-7128 |
| IngestDate | Wed Oct 01 14:46:34 EDT 2025 Tue Oct 07 08:05:12 EDT 2025 Mon Oct 06 17:40:44 EDT 2025 Fri Oct 03 11:01:25 EDT 2025 Sat Nov 29 14:10:53 EST 2025 Sat Nov 29 10:53:15 EST 2025 Wed Nov 26 10:59:38 EST 2025 Thu May 22 21:08:54 EDT 2025 Wed Feb 12 01:04:27 EST 2025 Mon Jul 21 09:15:56 EDT 2025 Sat Nov 29 01:48:45 EST 2025 Tue Nov 18 22:18:34 EST 2025 Fri Feb 21 02:38:03 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | tumor-specific immune responses nanoplexes spleen nano-bioceramics particles silica non-viral vector Particle Spleen Specificity Immune response Tumor Gene therapy Vector |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c578t-5d2b51e9000635737375935a4bf5ba198d3731c2c50a2aa23c1d5ed1fe4c0ba23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| PMID | 17344903 |
| PQID | 218714405 |
| PQPubID | 34384 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_70469295 proquest_miscellaneous_19854062 proquest_journals_2644637337 proquest_journals_218714405 gale_infotracmisc_A182280898 gale_infotracacademiconefile_A182280898 gale_incontextgauss_ISR_A182280898 gale_healthsolutions_A182280898 pubmed_primary_17344903 pascalfrancis_primary_18725022 crossref_primary_10_1038_sj_gt_3302937 crossref_citationtrail_10_1038_sj_gt_3302937 springer_journals_10_1038_sj_gt_3302937 |
| PublicationCentury | 2000 |
| PublicationDate | 2007-05-01 |
| PublicationDateYYYYMMDD | 2007-05-01 |
| PublicationDate_xml | – month: 05 year: 2007 text: 2007-05-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: Basingstoke – name: England – name: Houndmills |
| PublicationTitle | Gene therapy |
| PublicationTitleAbbrev | Gene Ther |
| PublicationTitleAlternate | Gene Ther |
| PublicationYear | 2007 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | C Lawson (BF3302937_CR4) 2006; 333 TP O'Connor (BF3302937_CR22) 2006; 7 YW Cho (BF3302937_CR23) 2003; 55 ML Read (BF3302937_CR18) 2005; 53 IA Khalil (BF3302937_CR8) 2006; 58 E Mastrobattista (BF3302937_CR10) 2006; 5 SJ Hwang (BF3302937_CR24) 2001; 3 TC Yih (BF3302937_CR14) 2006; 97 Y Tan (BF3302937_CR25) 2002; 69 Y Morita (BF3302937_CR13) 2004; 14 E Tupin (BF3302937_CR27) 2003; 10 Y Wang (BF3302937_CR2) 2006; 34 DJ Glover (BF3302937_CR5) 2005; 6 Y Byun (BF3302937_CR26) 1999; 94 E Wagner (BF3302937_CR1) 2004; 58 SS Larin (BF3302937_CR6) 2004; 11 RE Mebius (BF3302937_CR19) 2005; 5 CL Fong (BF3302937_CR21) 2006; 13 VG Pillarisetty (BF3302937_CR28) 2005; 174 M Nishikawa (BF3302937_CR17) 2005; 53 E Dauty (BF3302937_CR11) 2002; 9 R Kumar (BF3302937_CR16) 2004; 20 CL Fong (BF3302937_CR20) 2002; 9 UI Chaudhry (BF3302937_CR29) 2006; 20 T Niidome (BF3302937_CR3) 2002; 9 D Luo (BF3302937_CR12) 2004; 95 DA Jackson (BF3302937_CR7) 2006; 14 T Yamada (BF3302937_CR9) 2003; 21 R Kumar (BF3302937_CR15) 2003; 24 |
| References_xml | – volume: 97 start-page: 1184 year: 2006 ident: BF3302937_CR14 publication-title: J Cell Biochem doi: 10.1002/jcb.20796 – volume: 95 start-page: 333 year: 2004 ident: BF3302937_CR12 publication-title: J Control Release doi: 10.1016/j.jconrel.2003.11.019 – volume: 5 start-page: 606 year: 2005 ident: BF3302937_CR19 publication-title: Nat Rev Immunol doi: 10.1038/nri1669 – volume: 69 start-page: 73 year: 2002 ident: BF3302937_CR25 publication-title: Methods Mol Med – volume: 11 start-page: S18 issue: Suppl 1 year: 2004 ident: BF3302937_CR6 publication-title: Gene Ther doi: 10.1038/sj.gt.3302365 – volume: 333 start-page: 175 year: 2006 ident: BF3302937_CR4 publication-title: Methods Mol Biol – volume: 53 start-page: 47 year: 2005 ident: BF3302937_CR17 publication-title: Adv Genet doi: 10.1016/S0065-2660(05)53003-7 – volume: 24 start-page: 2611 year: 2003 ident: BF3302937_CR15 publication-title: Biomaterials doi: 10.1016/S0142-9612(03)00066-8 – volume: 55 start-page: 721 year: 2003 ident: BF3302937_CR23 publication-title: J Pharm Pharmacol doi: 10.1211/002235703765951311 – volume: 13 start-page: 245 year: 2006 ident: BF3302937_CR21 publication-title: Gene Ther doi: 10.1038/sj.gt.3302639 – volume: 9 start-page: 1647 year: 2002 ident: BF3302937_CR3 publication-title: Gene Ther doi: 10.1038/sj.gt.3301923 – volume: 21 start-page: 885 year: 2003 ident: BF3302937_CR9 publication-title: Nat Biotechnol doi: 10.1038/nbt843 – volume: 6 start-page: 299 year: 2005 ident: BF3302937_CR5 publication-title: Nat Rev Genet doi: 10.1038/nrg1577 – volume: 9 start-page: 1127 year: 2002 ident: BF3302937_CR20 publication-title: Gene Ther doi: 10.1038/sj.gt.3301783 – volume: 94 start-page: 53 year: 1999 ident: BF3302937_CR26 publication-title: Thromb Res doi: 10.1016/S0049-3848(98)00201-1 – volume: 3 start-page: 183 year: 2001 ident: BF3302937_CR24 publication-title: Curr Opin Mol Ther – volume: 34 start-page: 114 year: 2006 ident: BF3302937_CR2 publication-title: Biomed Eng – volume: 14 start-page: 263 year: 2004 ident: BF3302937_CR13 publication-title: Biomed Mater Eng – volume: 53 start-page: 19 year: 2005 ident: BF3302937_CR18 publication-title: Adv Genet doi: 10.1016/S0065-2660(05)53002-5 – volume: 58 start-page: 152 year: 2004 ident: BF3302937_CR1 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2004.01.003 – volume: 174 start-page: 2612 year: 2005 ident: BF3302937_CR28 publication-title: J Immunol doi: 10.4049/jimmunol.174.5.2612 – volume: 5 start-page: 115 year: 2006 ident: BF3302937_CR10 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd1960 – volume: 20 start-page: 5196 year: 2004 ident: BF3302937_CR16 publication-title: Langmuir doi: 10.1021/la049304f – volume: 7 start-page: 261 year: 2006 ident: BF3302937_CR22 publication-title: Nat Rev Genet doi: 10.1038/nrg1829 – volume: 9 start-page: 743 year: 2002 ident: BF3302937_CR11 publication-title: Gene Ther doi: 10.1038/sj.gt.3301759 – volume: 10 start-page: 569 year: 2003 ident: BF3302937_CR27 publication-title: Gene Ther doi: 10.1038/sj.gt.3301914 – volume: 14 start-page: 613 year: 2006 ident: BF3302937_CR7 publication-title: Mol Ther doi: 10.1016/j.ymthe.2006.03.026 – volume: 58 start-page: 32 year: 2006 ident: BF3302937_CR8 publication-title: Pharmacol Rev doi: 10.1124/pr.58.1.8 – volume: 20 start-page: 982 year: 2006 ident: BF3302937_CR29 publication-title: FASEB J doi: 10.1096/fj.05-5411fje |
| SSID | ssj0004782 |
| Score | 2.099999 |
| Snippet | We have compared the ability of several nanosized bioceramic particles including negatively charged silica (SiO
2
), neutrally charged hydroxyapatite (HA) and... We have compared the ability of several nanosized bioceramic particles including negatively charged silica (SiO(2)), neutrally charged hydroxyapatite (HA) and... We have compared the ability of several nanosized bioceramic particles including negatively charged silica (SiO2), neutrally charged hydroxyapatite (HA) and... We have compared the ability of several nanosized bioceramic particles including negatively charged silica (SiO sub(2)), neutrally charged hydroxyapatite (HA)... |
| SourceID | proquest gale pubmed pascalfrancis crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 828 |
| SubjectTerms | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animals Applied cell therapy and gene therapy Biocompatible Materials Biological and medical sciences Biological assay Biomedical and Life Sciences Biomedicine Biotechnology Cell Biology Cell Line, Tumor Ceramics in medicine Deoxyribonucleic acid DNA Female Fundamental and applied biological sciences. Psychology Gene Expression Gene Therapy Gene transfer Genetic Therapy - methods Health aspects Health. Pharmaceutical industry Human Genetics Humans Hydroxyapatite Immune response Industrial applications and implications. Economical aspects Injection Interferon-gamma - blood Interleukin 2 Interleukin-2 - blood Liposomes Luciferases - genetics Medical sciences Melanoma, Experimental Membrane Proteins - blood Methods Mice Mice, Inbred BALB C Microscopy, Confocal Microscopy, Electron Nanoparticles Nanotechnology Neoplasms - immunology Neoplasms - metabolism Neoplasms - therapy original-article Protamine sulfate Silicon dioxide Spleen Spleen - metabolism Transfection Transfection - methods Transfusions. Complications. Transfusion reactions. Cell and gene therapy Tumor cells Zirconia γ-Interferon |
| Title | Nanosized bioceramic particles could function as efficient gene delivery vehicles with target specificity for the spleen |
| URI | https://link.springer.com/article/10.1038/sj.gt.3302937 https://www.ncbi.nlm.nih.gov/pubmed/17344903 https://www.proquest.com/docview/218714405 https://www.proquest.com/docview/2644637337 https://www.proquest.com/docview/19854062 https://www.proquest.com/docview/70469295 |
| Volume | 14 |
| WOSCitedRecordID | wos000246210900005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1476-5462 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0004782 issn: 0969-7128 databaseCode: M7P dateStart: 19970201 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1476-5462 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0004782 issn: 0969-7128 databaseCode: BENPR dateStart: 19970201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Complete customDbUrl: eissn: 1476-5462 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0004782 issn: 0969-7128 databaseCode: 7X7 dateStart: 19970201 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Research Library customDbUrl: eissn: 1476-5462 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0004782 issn: 0969-7128 databaseCode: M2O dateStart: 19970201 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database (subscription) customDbUrl: eissn: 1476-5462 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0004782 issn: 0969-7128 databaseCode: 8C1 dateStart: 19970201 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYhhAS4vujbBQLIXhZtsROYvsJjWkTSKxUA6S-WY7jlE5TW-p2Av567hK3VUTHCy-REl_rjzvf_Wyf7wh5bauM5zxPIpkaWKAktopMwmxUOg5wXuRF3ARJ-iR6PTkYqH7YcPPBrXKpE2tFXU4s7pEfouHOueBcvJv-iDBrFJ6uhhQaW2QHoySw2nWvv74XKepkUYDSVSRAEYcYmzGXh_7iYDg_gMU8mDvRsklBM9-ZGg-jVDXpLTbhz7_OTmuTdHrvfztzn9wNYJQeNdLzgNxw44fk1lk4bn9EfoLunfjRb1fSYgSGbobJ6-l06UxHLebHpmgakb3UeOrqiBRgyCgIpqOlu0S_j1_0yn1vfoL7vrRxP6d4yxM9lWAhQAE7U8Ci8A19Ox6Tb6cnX48_RCFVQ2Rhys-jrGRFljhVQ55MQNdEpnhm0qLKCpMoWcKnxDKbxYYZw7hNysyVSeVSGxfw_oRsjydj94xQlbhMCFcBcCjSsrKKlU5Zw3llbAxwqUP2l8zSNsQxx3Qal7o-T-dS-ws9nOvA2w55syKfNgE8riN8iZzXzf3T1cTXR7ACYzKWSnbIq5oCw2aM0S9naBbe649fzltEbwNRNYFmWROuOUDnMNJWi3KvRQnz2raKuy0RXLdeCsCtjHXI7lK4dFA8XgNiE3hen8G_byhdyR30dlWMFaOr3dhNFl4DswDF5-x6CoF7KkxBFU-bmbBumuBpqmIOg7CcGuvKN4768383c5fcbjbT0cN0j2zPZwv3gty0V_ORn3XJlhiI-inhKY-TLtl5f9Lrn8PbGfvcrbXBH1IpYkY |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLamgQAJcb-Ujc1CXF7IlthxnTwgNAHTqnUFwZD2ZhzHKZ1GWup0MH4Uv5FzcmkV0fG2B17jE1-Pz8X-fA4hT00meJd3Ay8KNTgogck8HTDjpZaDOS-7iV8FSerLwSA6Ooo_rJDfzVsYhFU2MrEU1OnY4Bn5NiruLpecy9eT7x5mjcLb1SaFRsUW-_bsB7hs7lXvLazvM8Z23x2-2fPqrAKeAe4sPJGyRAQ2LrWzkFClFDEXOkwykWjwwVP4FBhmhK-Z1oybIBU2DTIbGj_RGOgARP6lED0hhAqy94t3mLJMTgVeQexJEPx1TE-fR9vueGtYbHHug3qVLR1Ya4LrE-1gVbIqncYye_evu9pSBe7e_N8m7xa5URvbdKfaHbfJis3vkCsHNZzgLvkJumXsRr9sSpMRKPKp_jYydNKABanB_N8UVT-yL9WO2jLiBihqChvP0tSeIK7ljJ7ar9UveK5NK3g9xVesiMQCR4eCb0DB1oZviF25Rz5fyLjvk9V8nNuHhMaBFVLaDAyjJEwzE7PUxkZznmnjgznYIS8b5lCmjtOO6UJOVIkX4JFyx2pYqJqXOuT5nHxSBSg5j3ATOU1V72vngk3tgIfJIj-Kow55UlJgWJAccUdDPXNO9T59bBG9qImyMXTL6PoZBwwOI4m1KNdblCC3TKt4o8Xyi95HEuxyxjpkrWFmVQtWp8AilYhHEFD7ktI5n8No58XYMEIJczueOQWLBV5Kl51PIfHMiMXQxINq5y26JnkYxj6HSWi24qLxpbP-6N_d3CRX9w4P-qrfG-yvkWvVxQGiadfJajGd2cfksjktRm66UUoaSr5c9O78AyC8uMY |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLamDk1IiPulbGwW4vJC1sSO6-QBocFWUW1U1QBpb8ZxnNJptKVpB-On8es4J3FaRXS87YHX-CTx5Vztz-cQ8sxkgrd5O_CiUEOAEpjM0wEzXmo5uPOynfhlkqQj2etFJydxf438ru7CIKyy0omFok7HBvfIW2i421xyLluZg0X09ztvJt89rCCFJ61VOY2SRQ7txQ8I3_LX3X1Y6-eMdQ4-vXvvuQoDngFOnXkiZYkIbFxYaiHh81LEXOgwyUSiIR5P4VFgmBG-ZlozboJU2DTIbGj8RGPSA1D_6xKcjLBB1t8e9PrHy1uZsihVBTFC7EkwAy7Dp8-jVn66O5jtcu6DsZU1i-jswo2JzmGNsrK4xirv96-T28Igdm79z1N5m9x0bjjdK-XmDlmzo7tk44MDGtwjP8HqjPPhL5vSZAgmfqq_DQ2dVDBCarAyOEWnABmb6pzaIhcHmHAKImlpas8Q8XJBz-3X8hXc8aYl8J7i_VbEaEEIRCFqoOCFwzNEtdwnn69k3A9IYzQe2UeExoEVUtoMXKYkTDMTs9TGRnOeaeODo9gkrypGUcZlcMdCImeqQBLwSOWnajBTjq-a5MWCfFKmLrmMcAe5TpU3bxcqT-1B7MkiP4qjJnlaUGDCkBHyy0DP81x1Px7XiF46omwM3TLaXfCAwWGOsRrlVo0SNJqpNW_X2H_Z-0iCx85Yk2xWjK2cys0V-KoSkQoCvr6idcHzMNpFM_4YQYYjO57nChYL4pc2u5xC4m4Si-EXD0spXHZN8jCMfQ6TUInl8ucrZ_3xv7u5QzZAKNVRt3e4Sa6XJwoIs90ijdl0bp-Qa-Z8Nsyn207tUPLlqsXzDzWxwuM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nanosized+bioceramic+particles+could+function+as+efficient+gene+delivery+vehicles+with+target+specificity+for+the+spleen&rft.jtitle=Gene+therapy&rft.au=Tan%2C+K&rft.au=Cheang%2C+P&rft.au=Ho%2C+I+A+W&rft.au=Lam%2C+P+Y+P&rft.date=2007-05-01&rft.pub=Nature+Publishing+Group+UK&rft.issn=0969-7128&rft.eissn=1476-5462&rft.volume=14&rft.issue=10&rft.spage=828&rft.epage=835&rft_id=info:doi/10.1038%2Fsj.gt.3302937&rft.externalDocID=10_1038_sj_gt_3302937 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0969-7128&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0969-7128&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0969-7128&client=summon |